Haemofiltration Study : IVOIRE (hIgh VOlume in Intensive Care)

NACompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Shock, SepticRenal Failure, Acute
Interventions
DEVICE

Venovenous haemofiltration (renal replacement therapy)

High Volume ultra filtration (70 ml/kg/h)

DEVICE

Venovenous haemofiltration (renal replacement therapy)

Conventional Volume (35 ml/kg/h)

Trial Locations (16)

29200

University Hospital, Brest

33077

Clinic Bordeaux Nord, Bordeaux

33505

Hospital R Boulin - Libourne, Libourne

33604

Service d'Anesthésie-Réanimation II, Groupe Hospitalier Sud, CHU de Bordeaux, Pessac

38600

University Hospital, Grenoble

47923

Hospital, Agen

59209

Hospital, Tourcoing

69317

University Hospital, Lyon

75908

Aphp - Hegp, Paris

Unknown

Cliniques de l'Europe, Brussels

Astrid Queen Military Hospital, Bruxelles (Neder Over Hembeek)

TIVOLI Hospital, La Louvière

University Hospital, Liège

St-Pierre Para-University Hospital, Ottignies-Louvain-la-Neuve

Hospital, Delf

Hospital, Heerlen

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

lead

University Hospital, Bordeaux

OTHER

NCT00241228 - Haemofiltration Study : IVOIRE (hIgh VOlume in Intensive Care) | Biotech Hunter | Biotech Hunter